DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,223,476 | -7.2% | 129,881 | -10.3% | 0.20% | +2.0% |
| Q2 2023 | $34,738,800 | -38.3% | 144,745 | -35.2% | 0.20% | -40.0% |
| Q1 2023 | $56,326,152 | -11.6% | 223,481 | -6.9% | 0.34% | -11.8% |
| Q4 2022 | $63,696,288 | +1.9% | 239,983 | -0.9% | 0.38% | -6.9% |
| Q3 2022 | $62,519,000 | -4.1% | 242,052 | -5.9% | 0.41% | +6.8% |
| Q2 2022 | $65,218,000 | -24.4% | 257,250 | -12.5% | 0.38% | -9.7% |
| Q1 2022 | $86,251,000 | -4.4% | 294,041 | +7.2% | 0.42% | -7.6% |
| Q4 2021 | $90,241,000 | -18.1% | 274,279 | -24.2% | 0.46% | -25.2% |
| Q3 2021 | $110,202,000 | -11.0% | 361,980 | -21.6% | 0.61% | -8.0% |
| Q2 2021 | $123,883,000 | -37.0% | 461,630 | -47.2% | 0.66% | -27.7% |
| Q1 2021 | $196,685,000 | -13.7% | 873,848 | -14.8% | 0.92% | -12.1% |
| Q4 2020 | $227,868,000 | -13.8% | 1,025,786 | -16.4% | 1.05% | -20.5% |
| Q3 2020 | $264,208,000 | +2.0% | 1,226,994 | -16.2% | 1.32% | -1.5% |
| Q2 2020 | $259,017,000 | +12.6% | 1,464,776 | -11.9% | 1.34% | -4.2% |
| Q1 2020 | $230,135,000 | -24.5% | 1,662,701 | -16.2% | 1.40% | +6.0% |
| Q4 2019 | $304,634,000 | -0.7% | 1,984,848 | -6.5% | 1.32% | -5.8% |
| Q3 2019 | $306,672,000 | -11.2% | 2,123,320 | -12.2% | 1.40% | -10.4% |
| Q2 2019 | $345,544,000 | +4.9% | 2,417,740 | -3.1% | 1.56% | +8.3% |
| Q1 2019 | $329,478,000 | +26.1% | 2,495,668 | -1.5% | 1.44% | +18.6% |
| Q4 2018 | $261,368,000 | -24.7% | 2,534,599 | -20.6% | 1.21% | -7.8% |
| Q3 2018 | $347,021,000 | +3.2% | 3,193,643 | -6.3% | 1.32% | +26.8% |
| Q2 2018 | $336,293,000 | -10.0% | 3,407,923 | -10.7% | 1.04% | -21.6% |
| Q1 2018 | $373,840,000 | +7.7% | 3,818,204 | +2.1% | 1.32% | +15.3% |
| Q4 2017 | $347,191,000 | +2.5% | 3,740,471 | -5.3% | 1.15% | +1.3% |
| Q3 2017 | $338,659,000 | +1.8% | 3,948,004 | +0.1% | 1.13% | +0.9% |
| Q2 2017 | $332,746,000 | +2.8% | 3,942,958 | +4.2% | 1.12% | +4.1% |
| Q1 2017 | $323,618,000 | +9.8% | 3,783,683 | -0.1% | 1.08% | -2.4% |
| Q4 2016 | $294,698,000 | +34.6% | 3,785,941 | +35.6% | 1.11% | +35.5% |
| Q3 2016 | $218,884,000 | -22.2% | 2,792,248 | +0.3% | 0.82% | -22.6% |
| Q2 2016 | $281,168,000 | +1.4% | 2,783,846 | -4.8% | 1.05% | +0.6% |
| Q1 2016 | $277,400,000 | -20.7% | 2,924,308 | -22.3% | 1.05% | -24.3% |
| Q4 2015 | $349,599,000 | +5.8% | 3,763,990 | -2.9% | 1.38% | +8.0% |
| Q3 2015 | $330,302,000 | +29.2% | 3,876,327 | +29.7% | 1.28% | +35.6% |
| Q2 2015 | $255,734,000 | +141.6% | 2,987,898 | +139.7% | 0.94% | +138.6% |
| Q1 2015 | $105,833,000 | -7.7% | 1,246,561 | -6.8% | 0.40% | -4.3% |
| Q4 2014 | $114,675,000 | +7.5% | 1,337,936 | -4.7% | 0.41% | -0.2% |
| Q3 2014 | $106,686,000 | -3.4% | 1,404,134 | +0.1% | 0.42% | -3.7% |
| Q2 2014 | $110,460,000 | +5.8% | 1,403,021 | +0.7% | 0.43% | +2.6% |
| Q1 2014 | $104,446,000 | -8.4% | 1,392,613 | -5.7% | 0.42% | -12.9% |
| Q4 2013 | $114,037,000 | -3.7% | 1,477,160 | -13.5% | 0.48% | -8.7% |
| Q3 2013 | $118,421,000 | +9.9% | 1,708,315 | +0.4% | 0.53% | -1.7% |
| Q2 2013 | $107,753,000 | – | 1,702,253 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |